Opzelura Ruxolitinib Cream For Vitiligo

Opzelura (ruxolitinib) cream is a topical treatment for nonsegmental vitiligo that may help restore skin pigmentation. Learn about its benefits and proper use Opzelura (ruxolitinib) cream is a topical prescription medicine used to treat nonsegmental vitiligo in eligible patients. It belongs to a class of medicines called Janus kinase (JAK) inhibitors and works by targeting immune pathways involved in the loss of pigment-producing melanocytes With consistent application as directed by a healthcare professional, ruxolitinib cream may help repigment areas of skin affected by vitiligo. Results can take time and vary from person to person.

Benefits

• Helps treat nonsegmental vitiligo in eligible patients.
• May help restore pigmentation in areas affected by vitiligo.
• Applied directly to affected skin.
• Targets JAK-related immune signaling involved in vitiligo.
• Designed for ongoing treatment under medical supervision.
• Convenient topical cream formulation.

How To Use

• Apply Opzelura exactly as prescribed by your healthcare professional.
• Apply a thin layer to the affected areas of skin.
• Use consistently according to your prescribed treatment schedule.
• Avoid contact with the eyes, mouth, and other mucous membranes.
• Wash your hands after application unless your hands are being treated.
• Do not apply to areas of skin that your healthcare professional has not instructed you to treat.
• Follow your prescriber’s instructions regarding the amount and duration of treatment.